Grant of Options to Director

RNS Number : 4149O
NetScientific PLC
08 February 2016
 

NetScientific plc

 

Grant of Options to Director

 

London, UK - 8 February 2016 - NetScientific plc ("NetScientific" or the "Group", AIM: NSCI), the transatlantic biomedical and healthcare technology group today announced that on 4 February 2016, options over a total of 200,000 ordinary shares of 5p each were granted to Francois Martelet.

 

Director

Position

   Number of Options
      Granted

Number of Options
Held

Francois Martelet

            CEO

200,000

559,020

 

The options have an exercise price of 86.2 pence per share being the average closing price for the ordinary shares over the five dealing days prior to the date on which the Option is granted. The options vest on the 4 February 2019, being the third anniversary from the date of Grant.

 

About NetScientific

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people's lives and society through improved diagnosis, prognosis and treatment.

For more information, please visit the website at www.netscientific.net. 

 

 Ends -

 

Contact Details

NetScientific

François R. Martelet, M.D., CEO

Mark Nanovich, Interim CFO

Tel: +44 (0)20 3514 1800

 

Investec (NOMAD and broker)

Gary Clarence / Daniel Adams

Tel: +44 (0)20 7597 4000

 

Instinctif Partners

Melanie Toyne-Sewell / Jayne Crook / Rosanna Forrest

Tel: +44 (0)20 7457 2020 Email: netscientific@instinctif.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEVLFBQLFFBBB

Companies

Emv Capital (EMVC)
UK 100

Latest directors dealings